Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 18/20 | 0.74 |
| ▸ | PPARA | Q07869 | 18/20 | 0.74 |
| ▸ | PPARD | Q03181 | 9/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | XBP1 | P17861 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5391225 | 1.00 | PPARG (0.74) | PPARGPPARAPPARDPOLBMAPT | |
| SCHEMBL5386342 | 1.00 | PPARG (0.74) | PPARGPPARAPPARDPOLBMAPT | |
| SCHEMBL5391232 | 1.00 | PPARG (0.74) | PPARGPPARAPPARDPOLBMAPT | |
| SCHEMBL14392086 | 1.00 | PPARG (0.74) | PPARGPPARAPPARDPOLBMAPT | |
| SCHEMBL5396324 | 0.95 | PPARG (0.75) | PPARGPPARAPPARDPOLBMAPT | |
| SCHEMBL14392293 | 0.95 | PPARG (0.75) | PPARGPPARAPPARDPOLBMAPT | |
| SCHEMBL5396328 | 0.95 | PPARG (0.75) | PPARGPPARAPPARDPOLBMAPT | |
| SCHEMBL14560789 | 0.93 | PPARA (0.64) | PPARGPPARAPPARDPOLBMAPT | |
| SCHEMBL14391962 | 0.90 | PPARA (0.59) | PPARGPPARAPPARDPOLBMAPT | |
| SCHEMBL5375447 | 0.90 | PPARA (0.59) | PPARGPPARAPPARDPOLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070276138-A1 | Modulators of peroxisome proliferator activated receptors | BROOKS DAWN A | 2007-11-29 | — | — | US | disclosed |
| US-20070276138-A1 | Modulators of peroxisome proliferator activated receptors | BROOKS DAWN A | 2007-11-29 | — | — | US | disclosed |
| US-7192982-B2 | Modulators of peroxisome proliferator activated receptors | LIGAND PHARMACEUTICALS, INC. (US) | 2007-03-20 | — | — | US | disclosed |
| US-7192982-B2 | Modulators of peroxisome proliferator activated receptors | LIGAND PHARMACEUTICALS, INC. (US) | 2007-03-20 | — | — | US | disclosed |
| US-20050020684-A1 | Modulators of peroxisome proliferator activated receptors | ELI LILLY AND COMPANY | 2005-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020684-A1 | Modulators of peroxisome proliferator activated receptors | NCOA4, PPARG, PPARA | PPARG 2/4885PPARA 3/4885PPARD 7/4885 |
| US-20070276138-A1 | Modulators of peroxisome proliferator activated receptors | PPARG, NCOA4, PPARA | PPARG 1/4885PPARA 3/4885PPARD 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.